US approves fourth Covid-19 vaccine dose for those above 50


By AGENCY
A fourth dose of either the Pfizer-BioNTech or Moderna vaccines for those aged 50 and above has been authorised in the US for improved protection against severe Covid-19. — AFP

The United States authorised a fourth dose of either the Pfizer-BioNTech or Moderna Covid-19 vaccines for people 50 and older on March 29 (2022), as authorities warn of a possible new wave driven by the SARS-CoV-2 Omicron BA.2 viral variant.

The US Food and Drug Administration (FDA) said in a statement that it had based its decision on emerging evidence that an additional booster, given four months after the last, improved protection against severe Covid-19 and wasn’t associated with new safety concerns.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Health

Faking symptoms to get antibiotics
Premature babies: Their fight to survive�
Diabetic retinopathy: When diabetes steals your sight
Plant proteins can help boost testosterone
How industry players influence government regulators�
When your brain won't let you fall sleep
Dispensing drugs to the disabled
One in four teens not getting enough physical activity
For babies, it's back to sleep, tummy to play�
Circadian depression:�When body clock disruptions affect the mind

Air Pollutant Index

Note: API is calculated based on 24hr running average of the most dominant parameter.

Highest API Readings

    Select State and Location to view the latest API reading

    Others Also Read